^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Bladder Cancer
    Drug:Balversa (erdafitinib) (pan-FGFR inhib)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Bladder Cancer: Subsequent-Line Systemic Therapy for Locally Advanced or Metastatic Disease (Stage IV)...Preferred regimens…Erdafitinib